FMR LLC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$7,639,602
+227.3%
200,042
+252.5%
0.00%
Q2 2023$2,333,961
-66.2%
56,746
-52.8%
0.00%
Q1 2023$6,895,862
+73.7%
120,116
+69.7%
0.00%
Q4 2022$3,969,252
+6.7%
70,791
-19.4%
0.00%
Q3 2022$3,721,000
-11.2%
87,855
+13.3%
0.00%
Q2 2022$4,190,000
+1645.8%
77,553
+1978.1%
0.00%
Q1 2022$240,000
+674.2%
3,732
+711.3%
0.00%
Q4 2021$31,000
+19.2%
460
+20.1%
0.00%
Q3 2021$26,000
-99.4%
383
-99.4%
0.00%
Q2 2021$4,472,000
-62.7%
65,533
-62.2%
0.00%
-100.0%
Q1 2021$11,978,000
-46.1%
173,359
-49.4%
0.00%
-50.0%
Q4 2020$22,227,000
-25.9%
342,373
-46.1%
0.00%
-33.3%
Q3 2020$29,985,000
-0.5%
635,000
-1.0%
0.00%0.0%
Q2 2020$30,125,000
-9.2%
641,100
-13.7%
0.00%
-40.0%
Q1 2020$33,189,000
-34.2%
742,975
-14.1%
0.01%
-16.7%
Q4 2019$50,409,000
-2.9%
864,960
+0.1%
0.01%0.0%
Q3 2019$51,916,000
-63.1%
864,254
-65.7%
0.01%
-62.5%
Q2 2019$140,766,000
-47.7%
2,520,422
-47.9%
0.02%
-50.0%
Q1 2019$269,306,000
-6.0%
4,833,188
-23.9%
0.03%
-17.9%
Q4 2018$286,416,000
-62.7%
6,350,685
-45.5%
0.04%
-54.7%
Q3 2018$767,451,000
+7.6%
11,650,977
+5.2%
0.09%
+4.9%
Q2 2018$713,542,000
+30.1%
11,078,120
+11.8%
0.08%
+26.2%
Q1 2018$548,511,000
+18.6%
9,911,637
+2.6%
0.06%
+20.4%
Q4 2017$462,498,000
-11.3%
9,663,558
-6.4%
0.05%
-14.3%
Q3 2017$521,218,000
+18.3%
10,325,236
+27.7%
0.06%
+14.5%
Q2 2017$440,690,000
+37.3%
8,084,562
+6.2%
0.06%
+34.1%
Q1 2017$320,857,000
-29.2%
7,615,884
+44.1%
0.04%
-32.8%
Q4 2016$453,501,000
+6.2%
5,286,174
+2.2%
0.06%
+7.0%
Q3 2016$427,150,000
+9.6%
5,174,442
+6.0%
0.06%
+7.5%
Q2 2016$389,633,000
+22.5%
4,883,849
+3.5%
0.05%
+20.5%
Q1 2016$317,956,000
-15.4%
4,720,249
-14.9%
0.04%
-13.7%
Q4 2015$375,992,000
+15.4%
5,547,236
+1.4%
0.05%
+10.9%
Q3 2015$325,703,000
-2.1%
5,469,407
+10.7%
0.05%
+7.0%
Q2 2015$332,812,000
+9.8%
4,940,056
+0.5%
0.04%
+10.3%
Q1 2015$303,113,000
+28.2%
4,916,676
+12.7%
0.04%
+25.8%
Q4 2014$236,481,000
+11.0%
4,360,705
+1.6%
0.03%
+6.9%
Q3 2014$213,075,000
-3.2%
4,292,414
-8.2%
0.03%
-3.3%
Q2 2014$220,105,000
+1.9%
4,677,114
-0.4%
0.03%0.0%
Q1 2014$216,016,000
-4.6%
4,697,012
-1.1%
0.03%
-6.2%
Q4 2013$226,480,000
+33.5%
4,747,012
+12.6%
0.03%
+23.1%
Q3 2013$169,617,000
+10.0%
4,214,087
+0.1%
0.03%
+4.0%
Q2 2013$154,201,0004,209,7030.02%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2023
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders